(Q35184733)

7 August 2017

1 reference

title

Gene therapy for neurological disease (English)

1 reference

7 August 2017

0 references

1

Mark H Tuszynski

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Expert Opinion on Biological Therapy

7 August 2017

published in

1 reference

7 August 2017

volume

3

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

815-828

1 reference

Neuronal progenitors as tools for cell replacement in the nervous system

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Building a better vector: the manipulation of AAV virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Retrovirus packaging cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Adeno-associated virus expression systems for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Development and application of herpes simplex virus vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Herpes simplex virus type 1/adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Growth-factor gene therapy for neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

The nerve growth factor 35 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Human beta-nerve growth factor gene sequence highly homologous to that of mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Nerve growth factor treatment after brain injury prevents neuronal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Potential use of nerve growth factor to treat Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

The cholinergic hypothesis of geriatric memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Distribution of radioiodinated recombinant human nerve growth factor in primate brain following intracerebroventricular infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Intracerebral NGF infusion induces hyperinnervation of cerebral blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Hypophagia is induced by intracerebroventricular administration of nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Reversible Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Nerve growth factor expressed in the medial septum following in vivo gene delivery using a recombinant adeno-associated viral vector protects cholinergic neurons from fimbria-fornix lesion-induced degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

NGF gene transfer to intrinsic basal forebrain neurons increases cholinergic cell size and protects from age-related, spatial memory deficits in middle-aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Brain-Derived Neurotrophic Factor Protects Dopaminergic Cells from 6-Hydroxydopamine Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Neurturin, a relative of glial-cell-line-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Functional recovery in parkinsonian monkeys treated with GDNF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Intrastriatal and intraventricular infusion of brain-derived neurotrophic factor in the cynomologous monkey: distribution, retrograde transport and co-localization with substantia nigra dopamine-containing neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Spontaneous and augmented growth of axons in the primate spinal cord: effects of local injury and nerve growth factor-secreting cell grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Neurotrophism without neurotropism: BDNF promotes survival but not growth of lesioned corticospinal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

In vivo gene therapy of metachromatic leukodystrophy by lentiviral vectors: correction of neuropathology and protection against learning impairments in affected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Correction of murine galactosialidosis by bone marrow-derived macrophages overexpressing human protective protein/cathepsin A under control of the colony-stimulating factor-1 receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Adenovirus vector-mediated gene transfer into human epileptogenic brain slices: prospects for gene therapy in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Thymidine kinase-mediated killing of rat brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Clinical trials of adenoviral-mediated suicide gene therapy of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Gene therapy for high grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Inducible gene expression systems for higher eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Modulation of neuronal survival and axonal growth in vivo by tetracycline-regulated neurotrophin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

High level transactivation by a modified Bombyx ecdysone receptor in mammalian cells without exogenous retinoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.5.815

21 January 2018

Identifiers

DOI

10.1517/14712598.3.5.815

1 reference

release_wplmplmyt5er5dw3xtwkekmtvu

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wplmplmyt5er5dw3xtwkekmtvu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference